Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
CA 2239072 C · Owner: Audonnet, Jean-Christophe Francis · Inventors: Riviere, Michel Albert Emile; Baudu, Philippe Guy Nicolas; Audonnet, Jean-Christophe Francis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A recombinant live vaccine including, as the vector a feline herpes virus that includes and expresses at least one nucleotide sequence coding for a polypeptide said sequence being inserted in sites ORF5 and/or ORF2 is disclosed. A multivalent vaccine formula and feline herpes virus DNA fragments are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 19, 1996 and granted April 24, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 19, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 19, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.